Comparison of the effects of different anti-inflammatory drugs on synovial fluid prostanoid concentrations in patients with rheumatoid arthritis. 1985

E Seppälä, and M Nissilä, and H Isomäki, and P Nuotio, and E Nykänen, and O Laitinen, and H Vapaatalo

The effects of one-day treatment with nine nonsteroidal anti-inflammatory drugs and prednisolone on human synovial fluid concentrations of prostanoids were studied. The doses were calculated so as to be approximately equipotent according to clinical experience and the recommendations of the manufacturers. Most of the drugs used reduced clearly PGE2 and TxB2 levels in synovial fluid, but only a slight diminution in 6-keto-PGF1 alpha values was found. Carprofen, diclofenac, indomethacin, naproxen and tolfenamic acid reduced significantly the synovial fluid PGE2 concentrations. Diclofenac and indomethacin also reduced significantly the synovial TxB2 concentrations.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D009288 Naproxen An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout. Aleve,Anaprox,Methoxypropiocin,Naprosin,Naprosyn,Naproxen Sodium,Proxen,Sodium Naproxenate,Synflex,Naproxenate, Sodium,Sodium, Naproxen
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D002227 Carbazoles Benzo-indoles similar to CARBOLINES which are pyrido-indoles. In plants, carbazoles are derived from indole and form some of the INDOLE ALKALOIDS.
D004008 Diclofenac A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt. Diclophenac,Dichlofenal,Diclofenac Potassium,Diclofenac Sodium,Diclonate P,Dicrofenac,Feloran,GP-45,840,Novapirina,Orthofen,Orthophen,Ortofen,SR-38,Sodium Diclofenac,Voltaren,Voltarol,Diclofenac, Sodium,GP 45,840,GP45,840,SR 38,SR38
D006146 Guanidines A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E Seppälä, and M Nissilä, and H Isomäki, and P Nuotio, and E Nykänen, and O Laitinen, and H Vapaatalo
January 2005, Clinical and experimental rheumatology,
E Seppälä, and M Nissilä, and H Isomäki, and P Nuotio, and E Nykänen, and O Laitinen, and H Vapaatalo
April 2003, Annals of the rheumatic diseases,
E Seppälä, and M Nissilä, and H Isomäki, and P Nuotio, and E Nykänen, and O Laitinen, and H Vapaatalo
October 1996, The Journal of rheumatology,
E Seppälä, and M Nissilä, and H Isomäki, and P Nuotio, and E Nykänen, and O Laitinen, and H Vapaatalo
October 1996, The Journal of rheumatology,
E Seppälä, and M Nissilä, and H Isomäki, and P Nuotio, and E Nykänen, and O Laitinen, and H Vapaatalo
December 1995, The Journal of rheumatology,
E Seppälä, and M Nissilä, and H Isomäki, and P Nuotio, and E Nykänen, and O Laitinen, and H Vapaatalo
November 1985, Seminars in arthritis and rheumatism,
E Seppälä, and M Nissilä, and H Isomäki, and P Nuotio, and E Nykänen, and O Laitinen, and H Vapaatalo
March 1991, Agents and actions,
E Seppälä, and M Nissilä, and H Isomäki, and P Nuotio, and E Nykänen, and O Laitinen, and H Vapaatalo
August 1967, Arthritis and rheumatism,
E Seppälä, and M Nissilä, and H Isomäki, and P Nuotio, and E Nykänen, and O Laitinen, and H Vapaatalo
January 1999, Journal of medicine,
E Seppälä, and M Nissilä, and H Isomäki, and P Nuotio, and E Nykänen, and O Laitinen, and H Vapaatalo
December 1983, Clinics in rheumatic diseases,
Copied contents to your clipboard!